Immunai

Israeli-founded AI biotech Immunai expands AstraZeneca most cancers collaboration | Israel Times

New York-headquartered, Israeli-founded AI biotech corporate Immunai has expanded its collaboration with AstraZeneca in oncology scientific building, with Immunai eligible…

- Advertisement -
Ad image